MedTrace Logo

CERvical Cancer The InFlammatory Index (CERTIFIKO)

NCT05673252 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 128

Last updated 2024-04-17

No results posted yet for this study

Summary

Although significant advances in screening and treatment , cervical cancer is the fifth most common female cancer in Europe. Major prognostic factors for oncological outcome are used to categorise patients at high, intermediate and low risk groups and to define the type of radical hysterectomy according "Querleu-Morrow classification". The goal of this prospective observational study is to evaluate the association between several inflammatory markers and risk groups according European guidelines in women with cervical cancer Human Papillomavirus (HPV)-associated, in order to optimize the treatment.

Conditions

Interventions

DIAGNOSTIC_TEST

Venous blood sample

Blood chemistry tests: neutrophil;lymphocyte; monocyte; platelet counts

PROCEDURE

biopsy

histopathology findings

Sponsors & Collaborators

  • University of Campania Luigi Vanvitelli

    lead OTHER

Principal Investigators

  • Carlo Ronsini, MD · University of Campania Luigi Vanvitelli

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-18
Primary Completion
2024-11-18
Completion
2024-11-18

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05673252 on ClinicalTrials.gov